Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells

C. H. Jin, K. Kusuhara, Y. Yonemitsu, A. Nomura, S. Okano, H. Takeshita, M. Hasegawa, K. Sueishi, T. Hara

研究成果: Contribution to journalReview article査読

31 被引用数 (Scopus)

抄録

Hematopoietic stem cells (HSCs) are a promising target for gene therapy, however, the low efficiencies of gene transfer using currently available vectors face practical limitations. We have recently developed a novel and efficient gene transfer agent, namely recombinant Sendai virus (SeV), and we have here characterized SeV-mediated gene transfer to human cord blood (CB) HSCs and primitive progenitor cells (PPC) using the jelly fish green fluorescent protein (GFP) gene. Even at a relatively low titer (10 multiplicity of infections), SeV achieved highly efficient GFP expression in CB CD34+ cells (85.5 ± 5.8%), as well as more immature CB progenitor cells, CD34+AC133+ (88.2 ± 3.7%) and CD34+CD38- (84.6 ± 5.7%) cells, without cytokines prestimulation, that was a clear contrast to the features of gene transfer using retroviruses. SeV-mediated gene transfer was not seriously affected by the cell cycle status. In vitro cell differentiation studies revealed that gene transfer occurred in progenitor cells of all lineages (GM-CFU, 73.0 ± 11.1%; BFU-E, 24.7 ± 4.0%; Mix-CFU, 59 ± 4.0%; and total, 50.0 ± 7.0%). These findings show that SeV could prove to be a promising vector for efficient gene transfer to CB HSCs, while preserving their ability to reconstitute the entire hematopoietic series.

本文言語英語
ページ(範囲)272-277
ページ数6
ジャーナルGene Therapy
10
3
DOI
出版ステータス出版済み - 2 2003

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics

フィンガープリント 「Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル